Preclinical Studies Identify Non-Apoptotic Low-Level Caspase-3 as Therapeutic Target in Pemphigus Vulgaris
Camille Luyet(University of Bern), Arnaud Galichet(University of Zurich)
Cited by 30
Related Papers
S100B and S100A6 Differentially Modulate Cell Survival by Interacting with Distinct RAGE (Receptor for Advanced Glycation End Products) Immunoglobulin Domains
|Journal of Biological Chemistry|2007|262